Matches in Wikidata for { <http://www.wikidata.org/entity/Q95604043> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q95604043 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95604043 description "scientific article published on 19 May 2020" @default.
- Q95604043 description "wetenschappelijk artikel" @default.
- Q95604043 description "наукова стаття, опублікована 19 травня 2020" @default.
- Q95604043 name "Clinical characteristics and early outcomes in patients with COVID-19 treated with tocilizumab at a United States academic center" @default.
- Q95604043 name "Clinical characteristics and early outcomes in patients with COVID-19 treated with tocilizumab at a United States academic center" @default.
- Q95604043 type Item @default.
- Q95604043 label "Clinical characteristics and early outcomes in patients with COVID-19 treated with tocilizumab at a United States academic center" @default.
- Q95604043 label "Clinical characteristics and early outcomes in patients with COVID-19 treated with tocilizumab at a United States academic center" @default.
- Q95604043 prefLabel "Clinical characteristics and early outcomes in patients with COVID-19 treated with tocilizumab at a United States academic center" @default.
- Q95604043 prefLabel "Clinical characteristics and early outcomes in patients with COVID-19 treated with tocilizumab at a United States academic center" @default.
- Q95604043 P1476 Q95604043-FC13D3EB-FF4A-4314-AF0B-21D04C6CC78B @default.
- Q95604043 P2093 Q95604043-00E2D4F7-9573-43CA-9810-7298FC20C202 @default.
- Q95604043 P2093 Q95604043-06FD3A80-F9DD-4201-8481-E15BED6AF83C @default.
- Q95604043 P2093 Q95604043-1F0F2B78-CCC7-4F07-94FC-F7D3B17E9695 @default.
- Q95604043 P2093 Q95604043-BC5E2D01-0984-4B8C-BF7B-ABCFE75E62D8 @default.
- Q95604043 P2093 Q95604043-FD8FB1D8-4BF7-46E4-9586-A88957AEE9D5 @default.
- Q95604043 P31 Q95604043-25F2CBA7-5253-4B28-8538-9A8156547AD7 @default.
- Q95604043 P356 Q95604043-8BA04625-7A1E-49DD-AE4A-FD0126D994EB @default.
- Q95604043 P50 Q95604043-1BF56590-E50B-4821-986A-4120F494600D @default.
- Q95604043 P50 Q95604043-22EF4A09-F0E6-470E-B009-11C4C1429412 @default.
- Q95604043 P50 Q95604043-30BD1CA0-45B0-4D02-A371-B312347657CE @default.
- Q95604043 P50 Q95604043-647BF108-E3AA-41DA-A671-ACD7FC04344C @default.
- Q95604043 P50 Q95604043-796E6B43-AA6E-44E4-B662-4A17FAD1FC3E @default.
- Q95604043 P50 Q95604043-87E1D0FF-2774-47CA-8B5C-74BFA60D31AD @default.
- Q95604043 P50 Q95604043-8D89F7AE-64A9-4343-9324-F4DA79D5B819 @default.
- Q95604043 P50 Q95604043-AC0EEA0F-2A13-40B0-AB0F-B9A067624911 @default.
- Q95604043 P50 Q95604043-EF6360C7-AE01-4121-905F-D97D3E1B0F67 @default.
- Q95604043 P577 Q95604043-C87C44D0-EC0D-423B-9CF2-0F939CC7FDED @default.
- Q95604043 P8299 Q95604043-BABAC378-4A97-42DA-BCA7-A4EF6191A268 @default.
- Q95604043 P921 Q95604043-8A9B4578-CA76-43AD-BB49-073D6FDBE91F @default.
- Q95604043 P921 Q95604043-92708C3B-6C97-4695-94F4-115FE0607EAB @default.
- Q95604043 P356 2020.05.13.20100404 @default.
- Q95604043 P1476 "Clinical characteristics and early outcomes in patients with COVID-19 treated with tocilizumab at a United States academic center" @default.
- Q95604043 P2093 "Ashley Marx" @default.
- Q95604043 P2093 "Brian Bramson" @default.
- Q95604043 P2093 "Min K Kim" @default.
- Q95604043 P2093 "Sonia Napravnik" @default.
- Q95604043 P2093 "Tanner Hedrick" @default.
- Q95604043 P31 Q13442814 @default.
- Q95604043 P356 "10.1101/2020.05.13.20100404" @default.
- Q95604043 P50 Q56613302 @default.
- Q95604043 P50 Q56778996 @default.
- Q95604043 P50 Q62067580 @default.
- Q95604043 P50 Q87874621 @default.
- Q95604043 P50 Q90568254 @default.
- Q95604043 P50 Q94501018 @default.
- Q95604043 P50 Q94935699 @default.
- Q95604043 P50 Q95604039 @default.
- Q95604043 P50 Q95604040 @default.
- Q95604043 P577 "2020-05-19T00:00:00Z" @default.
- Q95604043 P8299 "218676104" @default.
- Q95604043 P921 Q425154 @default.
- Q95604043 P921 Q84263196 @default.